Research Article

Association of Serum Alpha-Tocopherol and Retinol with the Extent of Coronary Lesions in Coronary Artery Disease

Table 1

Demographic, anthropometric, and clinical data of patients with coronary artery disease.

VariablesTotal ()Extent of coronary lesion (Friesinger index) value
0–4 ()5–9 ()10–15 ()

Age (years)58 ± 1056 ± 1060 ± 1162 ± 70.004a
Men, (%)99 (55.9)48 (53.3)30 (60.0)21 (56.8)0.592
BMI (kg/m2)27.8 ± 54.928.3 ± 5.126.8 ± 4.528.1 ± 4.50.212
Obesity, (%)45 (27.1)17 (25.4)8 (18.6)4 (12.9)0.279
Dyslipidemia, (%)165 (93.2)82 (91.1)48 (96.0)35 (94.6)0.508
Type 2 diabetes, (%)49 (27.7)20 (24.4)17 (34.0)12 (32.4)0.252
Hypertension, (%)154 (87.0)77 (85.5)45 (90.0)32 (86.5)0.751
Diastolic pressure (mmHg)84 ± 1581 ± 1488 ± 1683 ± 170.149
Systolic pressure (mmHg)143 ± 27138 ± 23152 ± 34142 ± 220.069
Alcohol consumption, (%)52 (29.5)31 (34.8)11 (22.0)10 (27.0)0.263
Cigarette smoking, (%)41 (23.2)16 (23.5)13 (30.2)8 (24.2)0.551
Physical activity, (%)65 (36.9)39 (43.3)16 (32.0)10 (27.8)0.183
Glucose (mmol/L)6.6 ± 3.25.7 ± 2.17.9 ± 4.56.7 ± 3.10.001b,c
Total cholesterol (mmol/L)4.6 ± 1.34.6 ± 1.14.7 ± 1.34.8 ± 1.60.648
HDL cholesterol (mmol/L)1.0 ± 0.30.9 ± 0.30.9 ± 0.30.9 ± 0.30.751
LDL cholesterol (mmol/L)2.8 ± 1.12.7 ± 1.02.8 ± 1.13.1 ± 1.40.248
Triglycerides (mmol/L)1.9 ± 1.21.9 ± 1.21.9 ± 1.41.7 ± 0.60.875
ALT (µkat/L)0.5 ± 0.30.5 ± 0.30.5 ± 0.40.5 ± 0.30.639
AST (µkat/L)0.5 ± 0.30.6 ± 0.30.5 ± 0.31.8 ± 1.00.506
Urea (mmol/L)6.4 ± 2.06.2 ± 1.86.3 ± 1.96.6 ± 2.60.831
Creatinine (μmol/L)82.1 ± 23.182.5 ± 22.283.0 ± 23.779.6 ± 25.00.758

Categorical variables are shown as number of patients (percentage) and compared using the chi-square test. Continuous variables are presented as mean ± standard deviation and compared using one-way ANOVA followed by Tukey’s test for multiples comparisons; was considered statistically significant. CAD: coronary artery disease; BMI: body mass index; HDL: high-density lipoprotein; LDL: low-density lipoprotein; AST: aspartate aminotransferase; ALT: aminotransferase. for comparison between 0–4 and 10–15 Friesinger index groups. for comparison between 0–4 and 5–9 Friesinger index groups. for comparison between 0–4 and 10–15 Friesinger index groups.